questionText: To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the efficacy of Esketamine in treating people with rare neurological conditions.
answerText: Currently, authorised Esketamine products are not licenced specifically intended for treating people with rare neurological conditions. Before new medicines intended to treat a specific condition can be placed onto the United Kingdom market, they must fir...
heading: Esketamine